Verve Therapeutics (NASDAQ:VERV) Shares Gap Down Following Analyst Downgrade
Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report)’s share price gapped down prior to trading on Tuesday after Royal Bank of Canada lowered their price target on the stock from $17.00 to $15.00. The stock had previously closed at $6.17, but opened at $5.86. Royal Bank of Canada currently has an outperform rating on the […]
Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report)’s share price gapped down prior to trading on Tuesday after Royal Bank of Canada lowered their price target on the stock from $17.00 to $15.00. The stock had previously closed at $6.17, but opened at $5.86. Royal Bank of Canada currently has an outperform rating on the […]
